Cyclosporin A therapy for patients with myelodysplastic syndrome: multicenter pilot studies in Japan
- 8 February 2003
- journal article
- clinical trial
- Published by Elsevier in Leukemia Research
- Vol. 27 (9) , 783-788
- https://doi.org/10.1016/s0145-2126(03)00008-0
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Good response to cyclosporine therapy in patients with myelodysplastic syndrromes having the HLA-DRB1*1501 alleleLeukemia, 2000
- Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapyBritish Journal of Haematology, 1995
- Immune‐mediated complications in patients with myelodysplastic syndromes – clinical and cytogenetic featuresEuropean Journal of Haematology, 1995
- Gene frequencies and haplotypic associations within the HLA region in 916 unrelated Japanese individualsTissue Antigens, 1994
- Clonality in myelodysplastic syndromes: demonstration of pluripotent stem cell origin using X‐linked restriction fragment length polymorphismsBritish Journal of Haematology, 1993
- Immune function parameters at diagnosis in patients with myelodysplastic syndromes: Correlation with the FAB classification and prognosisEuropean Journal of Haematology, 1991
- Immunoglobulin synthesis in myelodysplastic syndromes: Normal B-cell and immunoregulatory T-cell functionsClinical Immunology and Immunopathology, 1987
- Immunological abnormalities in myelodysplastic syndromes I. SERUM IMMUNOGLOBULINS AND AUTOANTIBODIESBritish Journal of Haematology, 1986
- Immunoregulatory abnormalities in myelodysplastic disordersAmerican Journal of Hematology, 1986
- Immune abnormalities in myelodysplastic syndromes.Journal of Clinical Pathology, 1985